DOI: 10.1055/s-00000031

Klinische Monatsblätter für Augenheilkunde

References

Singer MA, Awh CC, Sadda S. et al.
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.

Ophthalmology 2012;
119: 1175-1183

Download Bibliographical Data

Search in:
Access: